|
UBE2Z expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.7741810504931E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02309999863814E-08 |
| Normal-vs-Stage2 |
3.342400E-03 |
| Normal-vs-Stage3 |
1.93513999999784E-05 |
| Normal-vs-Stage4 |
3.042400E-02 |
| Stage1-vs-Stage2 |
5.790400E-01 |
| Stage1-vs-Stage3 |
1.132590E-01 |
| Stage1-vs-Stage4 |
4.714800E-01 |
| Stage2-vs-Stage3 |
5.139600E-01 |
| Stage2-vs-Stage4 |
8.125800E-01 |
| Stage3-vs-Stage4 |
7.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.65156818513424E-12 |
| Normal-vs-AfricanAmerican |
2.46789999999164E-05 |
| Normal-vs-Asian |
1.457010E-01 |
| Caucasian-vs-AfricanAmerican |
2.122600E-01 |
| Caucasian-vs-Asian |
7.437800E-01 |
| AfricanAmerican-vs-Asian |
4.141800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67500002756782E-09 |
| Normal-vs-Female |
2.89830381916545E-11 |
| Male-vs-Female |
1.264720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.418300E-04 |
| Normal-vs-Extreme_Weight |
1.28880000005438E-06 |
| Normal-vs-Obese |
2.21989999715788E-08 |
| Normal-vs-Extreme_Obese |
9.150200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.522000E-01 |
| Normal_Weight-vs-Obese |
1.168400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.279000E-01 |
| Extreme_Weight-vs-Obese |
1.262030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.012800E-01 |
| Obese-vs-Extreme_Obese |
8.228000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09639999999567E-05 |
| Normal-vs-Age(41-60Yrs) |
2.09643413739968E-12 |
| Normal-vs-Age(61-80Yrs) |
8.35539999965995E-07 |
| Normal-vs-Age(81-100Yrs) |
4.283400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.244020E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.608150E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.156900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.064000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.001000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.541170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.2354010843535E-11 |
| Normal-VS-Type2 PRCC |
1.78865000000084E-05 |
| Normal-VS-KIRP CIMP |
8.172000E-04 |
| Normal-VS-Unclassified PRCC |
2.39469999999686E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.024200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.282230E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.102800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.698600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.460600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.823500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.607300E-04 |
| Normal-vs-N1 |
6.184900E-04 |
| Normal-vs-N2 |
6.034200E-02 |
| N0-vs-N1 |
7.455800E-02 |
| N0-vs-N2 |
1.202780E-03 |
| N1-vs-N2 |
8.334000E-02 |
|
|
